NETCast
Claim This Podcastby Podcasting4Associations
Podcast Authority
Beta
Podcast Overview
<p>NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).</p><p>Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more. </p><p>Visit us at</p><p> <a href="https://nanets.net/" rel="noopener noreferrer" target="_blank">https://nanets.net/</a></p>
Language
🇺🇲
Publishing Since
9/27/2022
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for NETCast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 27, 2026
Beyond the Data: How Physicians Talk to Patients About Uncertainty
In this episode of NETCast, host Dr. Emil Lou is joined by a multidisciplinary panel of experts and a patient advocacy perspective to explore one of the most nuanced aspects of neuroendocrine tumor care: how physicians communicate uncertainty when the data are limited, evolving, or open to interpretation. Featuring perspectives from medical oncology, surgical oncology, nuclear medicine, and patient advocacy, the discussion examines the real-world challenges of navigating gray areas in NET care where multiple treatment paths may be reasonable and patient preferences play a critical role. The panel discusses how clinicians approach conversations when evidence is incomplete, communicate risk and treatment options, manage differing opinions within multidisciplinary teams, and build trust with patients facing complex decisions. Together, the group offers candid reflections and practical insights on balancing science, communication, and compassion in modern NET care. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
April 6, 2026
How Multidisciplinary Tumor Board Functions as the Engine Behind Complex NET Decision-Making
In this live recording from the Nashville Regional, we will explore the real-world impact of multidisciplinary NET specialty centers, particularly for patients initially diagnosed or managed in community settings. What structurally changes when a patient transitions from community-based care to an academic institution? And further, what distinguishes a general academic center from a dedicated NET specialty center? This conversation will examine how multidisciplinary tumor board functions as the operational engine behind complex decision-making, the role of pathology reassessment, referral timing, access to specialized imaging and therapies, and how community and specialty centers can collaborate to optimize outcomes for patients with neuroendocrine tumors. The focus will be on systems of care and collaboration, rather than on a specific therapy or guideline update. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
January 8, 2026
Feocromocitoma y Paraganglioma (Spanish podcast on Pheochromocytoma & Paraganglioma)
Este podcast médico presenta una discusión entre los Drs. Sarimar Agosto, Alejandro Román-González y Camilo Jiménez sobre el manejo del feocromocitoma y paraganglioma. Manejo multidisciplinario esencial (endocrinología, oncología, cirugía, genética, radiología nuclear). Referir pacientes a centros de excelencia. Cada caso requiere individualización del tratamiento según progresión, localización tumoral y estado global del paciente. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
45 total episodes available
Recent guests on NETCast
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Dr Renuka Iyer
Guest
Dr Aman Chauhan
Guest
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for NETCast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is NETCast?
<p>NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).</p><p>Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more. </p><p>Visit us at</p><p> <a href="https://nanets.net/" rel="noopener noreferrer" target="_blank">https://nanets.net/</a></p> - How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.